185 related articles for article (PubMed ID: 25565622)
21. The power of compassion: truth-telling among American doctors in the care of dying patients.
Miyaji NT
Soc Sci Med; 1993 Feb; 36(3):249-64. PubMed ID: 8426968
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
23. Development of a consensus approach for return of pathology incidental findings in the Genotype-Tissue Expression (GTEx) project.
Lockhart NC; Weil CJ; Carithers LJ; Koester SE; Little AR; Volpi S; Moore HM; Berkman BE
J Med Ethics; 2018 Sep; 44(9):643-645. PubMed ID: 29903854
[TBL] [Abstract][Full Text] [Related]
24. Revisiting Breen v Williams: Breathing Life into a Doctor-Patient Fiduciary Relationship.
Nestorovska D
J Law Med; 2018 Apr; 25(3):692-706. PubMed ID: 29978662
[TBL] [Abstract][Full Text] [Related]
25. Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.
Christenhusz GM; Devriendt K; Van Esch H; Dierickx K
Med Health Care Philos; 2015 Aug; 18(3):361-70. PubMed ID: 25407129
[TBL] [Abstract][Full Text] [Related]
26. Incidental findings and future testing methodologies: potential application of the ACMG 2013 recommendations.
Richardson A
J Law Biosci; 2014 Sep; 1(3):378-387. PubMed ID: 27774177
[TBL] [Abstract][Full Text] [Related]
27. Medical informed choice: understanding the element of time to meet the standard of care for valid informed consent.
Paterick ZR; Paterick TE; Paterick BB
Postgrad Med J; 2020 Nov; 96(1141):708-710. PubMed ID: 33139403
[TBL] [Abstract][Full Text] [Related]
28. Scanning the body, sequencing the genome: Dealing with unsolicited findings.
Wouters RHP; Cornelis C; Newson AJ; Bunnik EM; Bredenoord AL
Bioethics; 2017 Nov; 31(9):648-656. PubMed ID: 28975656
[TBL] [Abstract][Full Text] [Related]
29. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
30. Recommendations for returning genomic incidental findings? We need to talk!
Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
[TBL] [Abstract][Full Text] [Related]
31. Management of Incidental Findings in Clinical Genomic Sequencing.
Krier JB; Green RC
Curr Protoc Hum Genet; 2015 Oct; 87():9.23.1-9.23.16. PubMed ID: 26439717
[TBL] [Abstract][Full Text] [Related]
32. Differences in Conceptual Understanding of the "Actionability" of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan.
Ibuki T; Yamamoto K; Matsui K
AJOB Empir Bioeth; 2020; 11(3):187-194. PubMed ID: 32615058
[TBL] [Abstract][Full Text] [Related]
33. Automatic Placement of Genomic Research Results in Medical Records: Do Researchers Have a Duty? Should Participants Have a Choice?
Prince AE; Conley JM; Davis AM; Lázaro-Muñoz G; Cadigan RJ
J Law Med Ethics; 2015; 43(4):827-42. PubMed ID: 26711421
[TBL] [Abstract][Full Text] [Related]
34. Incidental variants are critical for genomics.
Biesecker LG
Am J Hum Genet; 2013 May; 92(5):648-51. PubMed ID: 23643378
[TBL] [Abstract][Full Text] [Related]
35. Dialogues, dilemmas, and disclosures: genomic research and incidental findings.
Bush LW; Rothenberg KH
Genet Med; 2012 Mar; 14(3):293-5. PubMed ID: 22391780
[No Abstract] [Full Text] [Related]
36. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
37. Informed consent in research.
Perry C
Natl Forum; 1999; 79(3):22-5. PubMed ID: 12455549
[TBL] [Abstract][Full Text] [Related]
38. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
39. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
[No Abstract] [Full Text] [Related]
40. [Ethical issues in genome-era].
Kosugi S
Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
